Errata: Vol. 59, No. 20

Details

• Journal Article:
  Morbidity and Mortality Weekly Report (MMWR)
• Description:
  In the report "FDA Licensure of Bivalent Human PapillomaVirus Vaccine (HPV2, Cervarix) for Use in Females and Updated HPV Vaccination Recommendations from the Advisory Committee on Immunization Practices (ACIP)," the second footnote under Table 2 should read as follows: "Phase III trial. According to protocol efficacy Analysis included females aged 15 through 25 years who received all 3 vaccine doses, were seronegative at day 1 and HPV DNA negative at day 1 through month 6 for the respective HPV type, and had normal or low grade cytology at day 1, with case counting beginning 1 day after third vaccine dose; mean duration of follow-up post third vaccine dose: 34.9 months."
• Subjects:
  Published Erratum
• Source:
  MMWR Morbidity Mortal Weekly Rep. 2010 Sep 10;59(36);1184
• Series:
  Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
• ISSN:
  0149-2195 (print) ; 1545-861X (digital)
• Document Type:
  Journal Article
• Genre:
  Published Erratum
• Pages in Document:
  1 pdf page
• Volume:
  59
• Issue:
  36
• Collection(s):
  Morbidity and Mortality Weekly Report (MMWR)
• Main Document Checksum:
  urn:sha-512:410f7abcd1b7a526ae8d5b65795c002e2b33cc622472849fb9b7d8fd3dabd45bed2c2c945248ab89d117698b67ac46c763b376396bcb42ab8297ba072e6391bc
• Download URL:
  https://stacks.cdc.gov/view/cdc/110992/cdc_110992_DS1.pdf
• File Type:
  [PDF - 140.45 KB ]